Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
1.
Article de Anglais | WPRIM | ID: wpr-922118

RÉSUMÉ

OBJECTIVE@#To investigate the molecular mechanisms underlying the effects of arsenic trioxide (As@*METHODS@#Transplantation of LVG hamster hearts to Lewis rats was performed by anastomosis of vessels in the neck using end-to-end anastomosis with a non-suture cuff technique. Four groups of recipient rats (n=6 in each) were treated with normal saline (control), As@*RESULTS@#Expression of Nrf2-ARE-HO-1 signaling pathway was upregulated in heart xenografts in rats treated with As@*CONCLUSION@#Combination treatment with As


Sujet(s)
Animaux , Cricetinae , Rats , Trioxyde d'arsenic , Transplantation cardiaque , Heme oxygenase-1/métabolisme , Hétérogreffes , Léflunomide , Facteur-2 apparenté à NF-E2/métabolisme , Rats de lignée LEW , Transduction du signal
2.
Chinese Medical Journal ; (24): 2834-2839, 2013.
Article de Anglais | WPRIM | ID: wpr-263573

RÉSUMÉ

<p><b>BACKGROUND</b>Endostatin is a potent inhibitor of tumor angiogenesis. In the preliminary studies, we developed a mutant endostatin containing Arg-Gly-Asp-Arg-Gly-Asp (RGDRGD) sequences. In this study, we compared the antitumor effects of mutant endostatin and Bcl-2 antisense oligonucleotides both in combination and individually.</p><p><b>METHODS</b>The artificially synthesized Bcl-2 ASODN (antisense oligonucleotides) included a translation-initiation site and was transfected into the bladder cancer cells by Lipofectamine. Cell growth was investigated by the tumor cell growth chart, MTT assay, caspase-3 activity detection assay, AO/EB fluorescein stain, and the annexin V-FITC apoptosis detection assay. In the in vivo study, UM-UC-3 bladder cancer cells were subcutaneously implanted into nude mice and the growth of tumor was examined. The ultrastructure of the tumor tissues in the treated and control groups were observed.</p><p><b>RESULTS</b>The cell growth chart showed that the cell population of the treated combination group decreased by 52.04% compared to the control group. The inhibition rate of the treated combination group was (79.66 ± 6.79)%, whereas those of the individual ASODN and ES groups were (53.39 ± 3.22)% and (50.22 ± 5.46)% respectively. In the caspase-3 activity detection using AO/EB fluorescein stain and annexin V-FITC apoptosis detection assay, the co-inhibitory effect was higher than the individual inhibitory effects (P < 0.05). There were significant differences in the inhibition of the solid tumor growth in the in vivo study.</p><p><b>CONCLUSIONS</b>Our findings indicated that Bcl-2 antisense oligonucleotides enhance the antitumor effects of mutant endostatin both in vitro and in vivo. We noted the synergistic effects of Bcl-2 antisense oligonucleotides combined with mutant endostatin.</p>


Sujet(s)
Animaux , Souris , Inhibiteurs de l'angiogenèse , Lignée cellulaire tumorale , Synergie des médicaments , Endostatines , Thionucléotides , Tumeurs de la vessie urinaire , Anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE